第一单位:
Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. Electronic address: Andrew.colebatch@health.nsw.gov.au.
作者:
Andrew J,Colebatch [1]
;
Peter,Ferguson [2]
;
Felicity,Newell [3]
;
Stephen H,Kazakoff [3]
;
Tom,Witkowski [4]
;
Alexander,Dobrovic [5]
;
Peter A,Johansson [3]
;
Robyn P M,Saw [6]
;
Jonathan R,Stretch [7]
;
Grant A,McArthur [8]
;
Georgina V,Long [9]
;
John F,Thompson [6]
;
John V,Pearson [3]
;
Graham J,Mann [10]
;
Nicholas K,Hayward [3]
;
Nicola,Waddell [3]
;
Richard A,Scolyer [11]
;
James S,Wilmott [7]
作者单位:
Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. Electronic address: Andrew.colebatch@health.nsw.gov.au.
[1]
Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
[2]
Queensland Institute of Medical Research, Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
[3]
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia.
[4]
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia; School of Cancer Medicine and Molecular Cancer Prevention Program, La Trobe University, Bundoora, Victoria, Australia; Department of Clinical Pathology, University of Melbourne, Parkville, Victoria, Australia.
[5]
Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; Department of Melanoma and Surgical Oncology, Discipline of Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
[6]
Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
[7]
Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
[8]
Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; Royal North Shore Hospital, Sydney, New South Wales, Australia.
[9]
Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, New South Wales, Australia.
[10]
Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
[11]
DOI
10.1016/j.jid.2018.12.033
PMID
30772300
发布时间
2020-06-01